Leukemia Updated Results of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL May 30, 2023
Other Cancers Amplifying Anti-Tumor Response: Dose Escalation of Teclistamab in Multiple Myeloma Patients May 30, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Cabozantinib Plus Nivolumab Shows Promise in Non-clear-Cell Renal Cell Carcinoma May 30, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) CTX130: A Promising Treatment Option for Relapsed or Refractory Renal Cell Carcinoma in COBALT-RCC Study May 30, 2023
Other Cancers Tislelizumab Improves Quality of Life in Asian Patients With Advanced ESCC May 30, 2023
